The ‘Transparency Effect’ in Pharmaceutical ESG Reports

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11320%2F26%3AUBK6NT6F" target="_blank" >RIV/00216208:11320/26:UBK6NT6F - isvavai.cz</a>

Výsledek na webu

<a href="https://iperstoria.it/article/view/1510" target="_blank" >https://iperstoria.it/article/view/1510</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.13136/2281-4582/2025.i25.1510" target="_blank" >10.13136/2281-4582/2025.i25.1510</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The ‘Transparency Effect’ in Pharmaceutical ESG Reports

Popis výsledku v původním jazyce

As the pharmaceutical sector has become increasingly competitive, companies have adopted a plethora of strategies and practices not only to publicise their products but also to be perceived by stakeholders as transparent and, by way of implication, honest and ethical. Drawing on a corpus of English-language Environmental, Social and Governance (ESG) reports, this study investigates the complexity and dynamism of the discursive strategies used by leading pharmaceutical companies listed on the stock exchange to build and enhance an image of transparency and credibility. By distinguishing between the level of the utterance – what is being communicated – and the enunciational level (Greimas &amp; Courtés 2007; Greimas 1983), which regards the writer and the context of enunciation, this paper conducts a semio-linguistic analysis in an attempt to explore different construals of transparency and opacity. The discourse of pharmaceutical companies is revealed as a sophisticated communicative construct, where various strategies are employed to create meaning effects that are used to foster an image of transparency and boost stakeholders’ trust.

Název v anglickém jazyce

The ‘Transparency Effect’ in Pharmaceutical ESG Reports

Popis výsledku anglicky

As the pharmaceutical sector has become increasingly competitive, companies have adopted a plethora of strategies and practices not only to publicise their products but also to be perceived by stakeholders as transparent and, by way of implication, honest and ethical. Drawing on a corpus of English-language Environmental, Social and Governance (ESG) reports, this study investigates the complexity and dynamism of the discursive strategies used by leading pharmaceutical companies listed on the stock exchange to build and enhance an image of transparency and credibility. By distinguishing between the level of the utterance – what is being communicated – and the enunciational level (Greimas &amp; Courtés 2007; Greimas 1983), which regards the writer and the context of enunciation, this paper conducts a semio-linguistic analysis in an attempt to explore different construals of transparency and opacity. The discourse of pharmaceutical companies is revealed as a sophisticated communicative construct, where various strategies are employed to create meaning effects that are used to foster an image of transparency and boost stakeholders’ trust.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

10201 - Computer sciences, information science, bioinformathics (hardware development to be 2.2, social aspect to be 5.8)

Projekt

—

Návaznosti

—

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Iperstoria

ISSN

2281-4582

e-ISSN

—

Svazek periodika

2025

Číslo periodika v rámci svazku

25

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

22

Strana od-do

270-291

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-105014221999